Page last updated: 2024-11-13

dolichol monophosphate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID24892715
CHEBI ID16214
SCHEMBL ID396770
MeSH IDM0091253

Synonyms (12)

Synonym
C00110
dolichyl phosphate
dolichyl monophosphate
CHEBI:16214
dolichol monophosphate
dolicholmonophosphate
12698-55-4
dolichyl-4 phosphate
LMPR03080015
SCHEMBL396770
Q5289051
[(6z,10e,14e)-3,7,11,15,19-pentamethylicosa-6,10,14,18-tetraenyl] dihydrogen phosphate

Research Excerpts

Overview

Dolichol monophosphate (Dol-P) functions as an obligate glycosyl carrier lipid. Dol-P is used in protein Glycosylation reactions.

ExcerptReferenceRelevance
"Dolichol monophosphate (Dol-P) functions as an obligate glycosyl carrier lipid in protein glycosylation reactions. "( Nogo-B receptor is necessary for cellular dolichol biosynthesis and protein N-glycosylation.
Gao, N; Harrison, KD; Kuo, A; Lehrman, MA; Park, EJ; Rush, JS; Sessa, WC; Waechter, CJ, 2011
)
1.81
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Pathways (6)

PathwayProteinsCompounds
protein N-glycosylation initial phase (eukaryotic)418
SARS-CoV-2 Infection7720
N-glycan biosynthesis010
glycophosphatidylinositol (GPI) anchor biosynthesis07
lipophosphoglycan (LPG) biosynthesis012
glycoinositolphospholipid (GIPL) biosynthesis011

Research

Studies (146)

TimeframeStudies, This Drug (%)All Drugs %
pre-199075 (51.37)18.7374
1990's50 (34.25)18.2507
2000's12 (8.22)29.6817
2010's6 (4.11)24.3611
2020's3 (2.05)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 9.30

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index9.30 (24.57)
Research Supply Index4.99 (2.92)
Research Growth Index4.29 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (9.30)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews11 (7.53%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other135 (92.47%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]